Evidence map›Paper›PMID 34315464›Full record

ArticleBMC medical genomics2021

Deletion of 2 amino acids in IHH in a Japanese family with brachydactyly type A1.

Nozomu Ozaki, Hiroko Okuda, Hatasu Kobayashi, Kouji H Harada, Sumiko Inoue, Shohab Youssefian, Akio Koizumi

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. A Novel HeterozygousPhenomics (Cham, Switzerland) · 2025
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nozomu OzakiDepartment of Pediatrics, Kadono-Sanjo Children's Clinic, Kyoto, Japan. nozk@leto.eonet.ne.jp.
Hiroko OkudaDepartment of Pain Pharmacogenetics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hatasu KobayashiEnvironmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Kouji H HaradaDepartment of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Sumiko InoueDepartment of Pain Pharmacogenetics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Shohab YoussefianDepartment of Pain Pharmacogenetics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Akio KoizumiDepartment of Pain Pharmacogenetics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kyoto University · JPKyoto Prefectural Institute of Public Health and Environment · JPMie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBrachydactyly type A1 (BDA1) is an autosomal dominant disorder characterized by uniform shortening of the middle phalanges in all digits. It is associated with variants in the Indian Hedgehog (IHH) gene, which plays a key role in endochondral ossification. To date, heterozygous pathogenic IHH variants involving several codons, which are restricted to a specific region of the N-terminal active fragment of IHH, have been reported. The purpose of this study was to identify the pathogenic variant in a Japanese family with BDA1 and to evaluate its pathogenesis with regard to previous reports.

methodsThe proband, a 9-year-old boy, his siblings, and his father had shortened digits and a short stature of variable severity. Based on physical examinations, radiographic findings and family history, they were diagnosed with BDA1. This family is the first case of an isolated malformation in Japan. Sanger sequencing of IHH was performed on these individuals and on the proband's unaffected mother. The significance of the variants was assessed using three-dimensional analysis methods.

resultsSanger sequencing showed a novel IHH heterozygous variant, NM_002181.4:c.544_549delTCAAAG(p.Ser182Lys183del) [NC_000002.12:g.219057461_219057466del].. These two residues are located outside the cluster region considered a hotspot of pathogenic variants. Three-dimensional modelling showed that S182 and K183 are located on the same surface as other residues associated with BDA1. Analysis of residue interactions across the interface between IHH and its interacting receptor protein revealed the presence of hydrogen bonds between them.

conclusionsWe report a novel variant, NM_002181.4:c.544_549delTCAAAG (p.Ser182Lys183del) [NC_000002.12:g.219057461_219057466del] in a Japanese family with BDA1. Indeed, neither variations in codons 182 or 183 nor with such two-amino-acid deletions in IHH have been reported previously. Although these two residues are located outside the cluster region considered a hotspot of pathogenic variants, we speculate that this variant causes BDA1 through impaired interactions between IHH and target receptor proteins in the same manner as other pathogenic variants located in the cluster region. This report expands the genetic spectrum of BDA1.

Indexed as

BrachydactylyHedgehog ProteinsPedigreeAsian PeopleChildFemaleHeterozygoteHumansJapanMaleSequence DeletionHedgehog ProteinsIHH protein, humanBrachydactyly type A1IHH geneShort stature

Identifiers

PMID34315464
PMCPMC8314500
OpenAlexW3186795344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.